Conference · London, United Kingdom
CNS Orphan Diseases - The Alternative Route in CNS
Pharmaceuticals
Key numbers
- Editions on record
- 2first in 2014
About CNS Orphan Diseases - The Alternative Route in CNS
The challenges of drug development in CNS is well known, the recent failures of the large phase III trials in Alzheimer's disease illustrates the problem. There is however an alternative route in CNS which can prove to be more accessible to small and medium sized companies, and that is CNS Orphan diseases. Diseases such as Huntington’s disease (HD), Amyotrophic lateral scerlosis (ALS), Progressive supranuclear palsy (PSP) or Fronto Temporal Dementia (FTD) can be initial substitutes for the likes of Alzheimer's disease or Parkinson's disease in which to test the effectiveness of a drug.
Speakers:
Susan McGoldrick
Consultant
The CNS Company
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2015 | 10 Mar 2015 | MSE Meeting Rooms London, United Kingdom | — | — |
| 2014 | 8 Apr 2014 | Holiday Inn London Bloomsbury London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is CNS Orphan Diseases - The Alternative Route in CNS?
The next dates haven't been confirmed. The last edition we have on record was 10 Mar 2015.
Where is it held?
The last edition we have was at MSE Meeting Rooms, London, United Kingdom.